Immunization with recombinant adenovirus induced NY-BR-1-specific CTL as well as CD4+ T cell responses and reduced outgrowth of the NY-BR-1 expressing tumor cell line EONY#17 in DR4tg mice. The gene discussed is ANKRD30A; the disease is neoplasm.